1 Min Read
Sept 27 (Reuters) - Kuros Biosciences AG:
* REPORTS FIRST PATIENT TREATED IN RANDOMIZED CONTROLLED TRIAL OF MAGNETOS IN SPINAL FUSION Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.